Latest News
TeraWulf Drops 17% as $19B Anthropic Deal Fails to Offset Financing Fears
TeraWulf shares fell 17.3% to $18.16, below its April offering price, despite a $19B Anthropic lease. Financing and regulatory risks overshadow the deal.
QXO Falls 6.6% as Housing Weakness and Share Dilution Weigh
QXO closed at $14.40 on Friday, down 6.6%, as weak housing data and a 30% increase in shares from the TopBuild acquisition weighed on the stock.
Fidelity to Close Two Income ETFs as Crypto Inflows Surge Led by Ether
Fidelity Canada will close two small income ETFs after Friday's close, as US spot crypto ETFs attracted US$181M in weekly inflows, led by ether.
Iovance Biotherapeutics Shares Surge 18% as Amtagvi Sales Targets Come into Focus
Iovance Biotherapeutics (IOVA) shares climbed 18.2% last week as investors eye the ambitious sales targets for its cancer therapy Amtagvi.
Ether ETF Inflows Surge to 58% as Crypto Fund Flows Slow
U.S. crypto ETFs attracted $181M in the week to July 17, with Ether funds accounting for 58% of inflows, up from 30% the prior week, signaling a rotation.
Buffett's $139B Share Transfer Plan Puts Focus on Abel's Role
Warren Buffett's plan to transfer $139 billion in Berkshire shares by 2034 raises questions about Greg Abel's leadership and governance at Berkshire Hathaway.
SpaceX Needs $1.33 Trillion Rebound to Hit $225 Target
SpaceX (NASDAQ:SPCX) needs to regain $1.33 trillion in equity value to hit the $225 median target, requiring an 81.5% recovery from Friday's close of $123.99.
IBM's Worst Week in History Sparks Doubts on Software Strategy
IBM shares plummeted 26% in their worst week ever, erasing $69B in market cap after preliminary Q2 results missed revenue and earnings estimates.



